We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Renal Cell Carcinoma

Journal Scan / Commentary · November 09, 2021

Individualized Selection of Adjuvant Systemic Therapies for Patients With RCC

European Urology Oncology


Additional Info

European Urology Oncology
Adjuvant Systemic Therapies for Patients with Renal Cell Carcinoma: Choosing Treatment Based on Patient-level Characteristics
Eur Urol Oncol 2021 Sep 21;[EPub Ahead of Print], P Msaouel, P Grivas, T Zhang

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading